Home » Story links » MagicDiligence's story links

MFI Stock Review: Cephalon (CEPH)

By MagicDiligence on Thu, 2009-11-05 08:07
(via www.magicdiligence.com)

Cephalon has three drugs with good growth potential. If sales develop according to the company's plan, the current price will prove to be a bargain.